Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 4/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.39 |
| ▸ | NPC1 | O15118 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 3/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.37 |
| ▸ | CDK9 | P50750 | 1/20 | 0.37 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | PPARA | Q07869 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ABAT | P80404 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carbamic Acid Phenyl Ester SCHEMBL1903919 | 0.76 | ALDH1A1 (0.41) | RAB9ASMN1; SMN2NPC1KMT2AMEN1 | |
| SCHEMBL560448 | 0.74 | CYP1A2 (0.45) | CYP1A2CYP3A4CYP2C9CYP2C19RAB9A | |
| SCHEMBL672472 | 0.74 | SMN1; SMN2 (0.47) | CYP1A2CYP3A4CYP2C9CYP2C19RAB9A | |
| SCHEMBL27872143 | 0.74 | EPHX2 (0.42) | CYP1A2CYP3A4CYP2C9CYP2C19RAB9A | |
| SCHEMBL7634 | 0.70 | EPHX2 (0.70) | CYP3A4RAB9ASMN1; SMN2NPC1TSHR | |
| Benzene SCHEMBL28162617 | 0.70 | EPHX2 (0.70) | CYP3A4RAB9ASMN1; SMN2NPC1TSHR | |
| Alcohol SCHEMBL27965507 | 0.69 | NAPRT (0.58) | RAB9ASMN1; SMN2NPC1TSHRKMT2A | |
| SCHEMBL672473 | 0.68 | RAB9A (0.48) | CYP1A2CYP3A4CYP2C9CYP2C19RAB9A | |
| Fluoride SCHEMBL10885265 | 0.68 | EPHX2 (0.67) | CYP3A4RAB9ASMN1; SMN2NPC1TSHR | |
| Bromide SCHEMBL5706299 | 0.68 | EPHX2 (0.67) | CYP3A4RAB9ASMN1; SMN2NPC1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4176721-B1 | BIOCIDAL POLYMER BLENDS | LANXESS DEUTSCHLAND GMBH (DE) | 2026-01-07 | — | — | EP | claimed |
| EP-2413697-B1 | STABILISATION OF COMPOUNDS CONTAINING IODINE | LANXESS DEUTSCHLAND GMBH (DE) | 2017-11-08 | — | — | EP | claimed |
| US-20170215421-A1 | BIOCIDE AGENTS | LANXESS DEUTSCHLAND GMBH (DE) | 2017-08-03 | — | — | US | claimed |
| EP-2779830-B1 | STABILIZATION OF COMPOUNDS CONTAINING IODINE HAVING POLYMERS COMPRISING NITROGEN | LANXESS DEUTSCHLAND GMBH (DE) | 2017-05-17 | — | — | EP | claimed |
| US-9585384-B2 | Stabilization of compounds comprising iodine | LANXESS DEUTSCHLAND GMBH (DE) | 2017-03-07 | — | — | US | claimed |
| US-9328065-B2 | Nitrogen-containing inorganic carrier materials | LANXESS DEUTSCHLAND GMBH (DE) | 2016-05-03 | — | — | US | claimed |
| US-9326502-B2 | Stabilization of compounds containing iodine having polymers comprising nitrogen | LANXESS DEUTSCHLAND GMBH (DE) | 2016-05-03 | — | — | US | claimed |
| US-9296878-B2 | Fungicide formulations for plasticized PVC | LANXESS DEUTSCHLAND GMBH (DE) | 2016-03-29 | — | — | US | claimed |
| EP-2831161-B1 | FUNGICIDE FORMULATIONS FOR PLASTICIZED PVC | LANXESS DEUTSCHLAND GMBH (DE) | 2015-11-18 | — | — | EP | claimed |
| US-20150203660-A1 | FUNGICIDE FORMULATIONS FOR PLASTICIZED PVC | LANXESS DEUTSCHLAND GMBH (DE) | 2015-07-23 | — | — | US | claimed |
| US-20150087700-A1 | NITROGEN-CONTAINING INORGANIC CARRIER MATERIALS | LANXESS DEUTSCHLAND GMBH (DE) | 2015-03-26 | — | — | US | claimed |
| US-8921451-B2 | Stabilization of compounds comprising iodine | LANXESS DEUTSCHLAND GMBH (DE) | 2014-12-30 | — | — | US | claimed |
| US-20140303277-A1 | STABILIZATION OF COMPOUNDS CONTAINING IODINE HAVING POLYMERS COMPRISING NITROGEN | LANXESS DEUTSCHLAND GMBH (DE) | 2014-10-09 | — | — | US | claimed |
| EP-1981629-B1 | IPBC-CONTAINING COACERVATES | LANXESS DEUTSCHLAND GMBH (DE) | 2013-10-16 | — | — | EP | claimed |
| US-20120309897-A1 | Polymers containing heterocyclic 3-ring compounds and iodine-containing compounds | LANXESS DEUTSCHLAND GMBH (DE) | 2012-12-06 | — | — | US | claimed |
| US-20120208918-A1 | STABILIZATION OF COMPOUNDS COMPRISING IODINE | LANXESS DEUTSCHLAND GMBH (DE) | 2012-08-16 | — | — | US | claimed |
| US-20120186487-A1 | INORGANIC CARRIER MATERIALS CONTAINING HETEROCYCLIC 3-RING COMPOUNDS | LANXESS DEUTSCHLAND GMBH (DE) | 2012-07-26 | — | — | US | claimed |
| US-20120178804-A1 | NITROGEN-CONTAINING INORGANIC CARRIER MATERIALS | LANXESS DEUTSCHLAND GMBH (DE) | 2012-07-12 | — | — | US | claimed |
| US-20110009268-A1 | IPBC-CONTAINING COACERVATES | LANXESS DEUTSCHLAND GMBH (DE) | 2011-01-13 | — | — | US | claimed |
| WO-2022270091-A1 | ANTIMICROBIAL PARTICLE DISPERSION | 三菱鉛筆株式会社 | 2022-12-29 | — | — | WO | disclosed |
| US-20170215421-A1 | BIOCIDE AGENTS | LANXESS DEUTSCHLAND GMBH (DE) | 2017-08-03 | — | — | US | disclosed |
| US-9585384-B2 | Stabilization of compounds comprising iodine | LANXESS DEUTSCHLAND GMBH (DE) | 2017-03-07 | — | — | US | disclosed |
| US-9328065-B2 | Nitrogen-containing inorganic carrier materials | LANXESS DEUTSCHLAND GMBH (DE) | 2016-05-03 | — | — | US | disclosed |
| US-9326502-B2 | Stabilization of compounds containing iodine having polymers comprising nitrogen | LANXESS DEUTSCHLAND GMBH (DE) | 2016-05-03 | — | — | US | disclosed |
| US-20150087700-A1 | NITROGEN-CONTAINING INORGANIC CARRIER MATERIALS | LANXESS DEUTSCHLAND GMBH (DE) | 2015-03-26 | — | — | US | disclosed |
| US-20150080491-A1 | STABILIZATION OF COMPOUNDS COMPRISING IODINE | LANXESS DEUTSCHLAND GMBH (DE) | 2015-03-19 | — | — | US | disclosed |
| US-8921451-B2 | Stabilization of compounds comprising iodine | LANXESS DEUTSCHLAND GMBH (DE) | 2014-12-30 | — | — | US | disclosed |
| US-20140303277-A1 | STABILIZATION OF COMPOUNDS CONTAINING IODINE HAVING POLYMERS COMPRISING NITROGEN | LANXESS DEUTSCHLAND GMBH (DE) | 2014-10-09 | — | — | US | disclosed |
| US-20120309897-A1 | Polymers containing heterocyclic 3-ring compounds and iodine-containing compounds | LANXESS DEUTSCHLAND GMBH (DE) | 2012-12-06 | — | — | US | disclosed |
| US-20120208918-A1 | STABILIZATION OF COMPOUNDS COMPRISING IODINE | LANXESS DEUTSCHLAND GMBH (DE) | 2012-08-16 | — | — | US | disclosed |
| US-20120186487-A1 | INORGANIC CARRIER MATERIALS CONTAINING HETEROCYCLIC 3-RING COMPOUNDS | LANXESS DEUTSCHLAND GMBH (DE) | 2012-07-26 | — | — | US | disclosed |
| US-20120178804-A1 | NITROGEN-CONTAINING INORGANIC CARRIER MATERIALS | LANXESS DEUTSCHLAND GMBH (DE) | 2012-07-12 | — | — | US | disclosed |
| US-20110009268-A1 | IPBC-CONTAINING COACERVATES | LANXESS DEUTSCHLAND GMBH (DE) | 2011-01-13 | — | — | US | disclosed |
| US-20110009268-A1 | IPBC-CONTAINING COACERVATES | LANXESS DEUTSCHLAND GMBH (DE) | 2011-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120178804-A1 | NITROGEN-CONTAINING INORGANIC CARRIER MATERIALS | SLCO4C1, SLCO2B1, SLCO2A1 | CYP1A2 4475/4885CYP3A4 4280/4885CYP2C9 3685/4885 |
| US-20140303277-A1 | STABILIZATION OF COMPOUNDS CONTAINING IODINE HAVING POLYMERS COMPRISING NITROGEN | NISCH, INMT, TPO | CYP1A2 3844/4885CYP3A4 3762/4885CYP2C9 2715/4885 |
| US-20150087700-A1 | NITROGEN-CONTAINING INORGANIC CARRIER MATERIALS | SLCO4C1, SLCO2B1, SLCO2A1 | CYP1A2 4475/4885CYP3A4 4280/4885CYP2C9 3685/4885 |
| US-20120186487-A1 | INORGANIC CARRIER MATERIALS CONTAINING HETEROCYCLIC 3-RING COMPOUNDS | SLCO4C1, SLCO1B3, ABCC3 | CYP1A2 1477/4885CYP3A4 665/4885CYP2C9 912/4885 |
| US-20120309897-A1 | Polymers containing heterocyclic 3-ring compounds and iodine-containing compounds | TPO, BRD4, SSTR3 | CYP1A2 2472/4885CYP3A4 1933/4885CYP2C9 2845/4885 |
| US-20120208918-A1 | STABILIZATION OF COMPOUNDS COMPRISING IODINE | TPO, AZI2, NISCH | CYP1A2 2365/4885CYP3A4 2697/4885CYP2C9 1569/4885 |
| US-20150080491-A1 | STABILIZATION OF COMPOUNDS COMPRISING IODINE | TPO, AZI2, NISCH | CYP1A2 2365/4885CYP3A4 2697/4885CYP2C9 1569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.